HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcomes of curettage and anhydrous alcohol adjuvant for low-grade chondrosarcoma of long bone.

AbstractBACKGROUND:
Low-grade chondrosarcoma of long bones can be treated successfully with extended intralesional curettage using adjuvants. However, there is no study reporting the use of anhydrous alcohol as an adjuvant in the treatment of low-grade chondrosarcoma. We asked (1) whether intralesional curettage and anhydrous alcohol adjuvant for low-grade chondrosarcoma is associated with good oncologic outcomes; and we report (2) the complications of the procedure.
METHODS:
Thirty-six patients (13 men, 23 women) with a mean age of 46 years (range, 18-67 years) were treated for low-grade chondrosarcoma and followed up for a median of 62 months (range, 24-169 months). After intralesional curettage, and additional burring, anhydrous alcohol was used as an adjuvant therapy.
RESULTS:
At the time of last follow-up, there were no local recurrences or distant metastases. Six patients developed complications: 4 postoperative fractures (11%), 1 intra-articular loose body (3%) and 1 postoperative joint stiffness (3%).
CONCLUSION:
Anhydrous alcohol is a reasonable adjuvant for the curettage of low-grade chondrosarcoma of long bones. A long-term follow-up study is necessary, considering the slow biological progression of low-grade chondrosarcoma.
AuthorsWanlim Kim, Ilkyu Han, Eo Jin Kim, Seungcheol Kang, Han-Soo Kim
JournalSurgical oncology (Surg Oncol) Vol. 24 Issue 2 Pg. 89-94 (Jun 2015) ISSN: 1879-3320 [Electronic] Netherlands
PMID25912950 (Publication Type: Journal Article)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • Alcohols
  • Solvents
Topics
  • Adolescent
  • Adult
  • Aged
  • Alcohols (therapeutic use)
  • Bone Neoplasms (surgery)
  • Chemotherapy, Adjuvant
  • Chondrosarcoma (surgery)
  • Curettage (methods)
  • Female
  • Femoral Neoplasms (drug therapy, surgery)
  • Fractures, Spontaneous (etiology)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications (etiology)
  • Retrospective Studies
  • Solvents (therapeutic use)
  • Tibia
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: